Goldman Sachs Group »

Allogene Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $11M 3.3M 3.21
2023-09-30 $4.5M 1.4M 3.17
2023-06-30 $7.5M 1.5M 4.97
2023-03-31 $5.7M 1.2M 4.94
2022-12-31 $10M 1.6M 6.29
2022-06-30 $23M 2.0M 11.40
2022-03-31 $27M 3.0M 9.11
2021-12-31 $27M 1.8M 14.92
2021-09-30 $51M 2.0M 25.70
2021-03-31 $45M 1.3M 35.30
2020-12-31 $35M 1.4M 25.24
2020-09-30 $35M 927k 37.71
2020-06-30 $15M 346k 42.81
2019-12-31 $4.5M 175k 25.98
2019-09-30 $2.9M 105k 27.25
2019-06-30 $2.1M 79k 26.85
2019-03-31 $1.8M 63k 28.90
2018-12-31 $1.6M 61k 26.92